Business Standard

Monday, December 23, 2024 | 04:19 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Pfizer seeks US govt approval to ease handling of Covid-19 vaccine

Pfizer/BioNTech's vaccine, along with Moderna Inc's two-dose shot, won the US emergency use authorization (EUA) and is being widely distributed as part of the country's mass vaccination efforts

Pfizer
Premium

Reuters
Pfizer Inc and BioNTech SE have submitted new temperature data to the US health regulator which they said on Friday could allow their COVID-19 vaccine to be stored in pharmacy freezers rather than in ultra-cold storage facilities.
 
If approved, the less onerous storage requirements would provide a significant logistical relief for the roll-out of the vaccine, particularly in lower-income countries that do not have the necessary infrastructure.
 
Pfizer/BioNTech's vaccine, along with Moderna Inc's two-dose shot, won the US emergency use authorization (EUA) and is being widely distributed as part of the country's mass vaccination efforts.
 
The new data has been

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in